Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61,100 | 34,200 | 47,700 | 28,000 | 0 |
| Receivables | 118,500 | 108,400 | 100,600 | 129,000 | 133,000 |
| Inventories | 120,500 | 111,800 | 86,600 | 87,000 | 169,000 |
| Income taxes - deferred | 11,900 | 27,600 | 18,200 | 23,000 | N/A |
| Other current assets | 6,400 | 3,400 | 20,000 | 20,000 | 54,000 |
| TOTAL | $360,200 | $320,200 | $292,000 | $301,000 | $356,000 |
| Non-Current Assets | |||||
| PPE Net | 209,900 | 209,400 | 187,800 | 183,000 | 226,000 |
| Investments And Advances | 35,400 | 23,500 | 92,900 | 98,000 | 1,000 |
| Intangibles | 419,200 | 398,800 | 402,400 | 0 | 0 |
| Other Non-Current Assets | 76,700 | 52,500 | 7,800 | 525,000 | 854,000 |
| TOTAL | $741,200 | $684,200 | $690,900 | $806,000 | $1,081,000 |
| Total Assets | $1,101,400 | $1,004,400 | $982,900 | $1,107,000 | $1,437,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 1,100 | 61,000 | 0 |
| Accounts payable and accrued liabilities | 184,100 | 177,300 | 183,500 | 177,000 | 156,000 |
| TOTAL | $184,100 | $177,300 | $184,600 | $238,000 | $156,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 255,800 | 245,500 | 309,800 | 367,000 | 0 |
| aiOther Non-Current Liabilities | 26,400 | 42,200 | 29,800 | 62,000 | 57,000 |
| TOTAL | $282,200 | $287,700 | $339,600 | $429,000 | $57,000 |
| Total Liabilities | $466,300 | $465,000 | $524,200 | $667,000 | $213,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 715,946 | 722,703 | 712,856 | N/A | N/A |
| Common Shares | 62,600 | 60,200 | 59,300 | 59,000 | 0 |
| Retained earnings | 222,400 | 143,400 | 87,700 | 103,000 | 418,000 |
| Other shareholders' equity | -32,100 | -44,200 | 25,500 | 1,000 | 806,000 |
| TOTAL | $635,100 | $539,400 | $458,700 | $440,000 | $1,224,000 |
| Total Liabilities And Equity | $1,101,400 | $1,004,400 | $982,900 | $1,107,000 | $1,437,000 |